StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.95+0.10 (+3.33%)

Close on Nov 18, 2026Market cap $242.04MP/E –Yield –

Lexeo Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lexeo Therapeutics's market cap was $241.37M on Nov 11, 2026, against $541.65M a year earlier. Over the last 3 years it ranged from $20.77M to $547.59M, with a median of $305.98M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$241.37M-55.8%
2025Dec 31, 2025$545.50M+150.8%
2024Dec 31, 2024$217.52M+892.5%
2023Dec 29, 2023$21.92M–

More Lexeo Therapeutics figures

See a number that looks wrong?